• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西洛他唑对兔实验性脑梗死的影响。

Effect of cilostazol on experimental cerebral infarction in rabbits.

作者信息

Watanabe K, Nakase H, Kimura Y

出版信息

Arzneimittelforschung. 1986 Jul;36(7):1022-4.

PMID:3094546
Abstract

The effects of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3, 4-dihydro-2(1H)-quinolinone (cilostazol, OPC-13013), acetylsalicylic acid (ASA) and ifenprodil on experimentally induced cerebral infarction were studied in anesthetized rabbits. Cerebral infarction was induced by injecting arachidonic acid (AA) at a dose of 0.5 mg/kg into the unilateral intracarotid artery. After the injection of AA, the brain was perfused with Indian ink, and the degree of thrombus formation was determined by calculating the percentage of perfused area in the hemispheres. The intracarotid injection of AA produced a non-perfused area amounting to 84% of the hemisphere in the injected side and 41% of the hemisphere in the non-injected side. Intravenously administered cilostazol did not produce a definite reduction in carbon-deficient area at 0.1 mg/kg, but it did produce a 49% reduction in the injected side and a 55% reduction in the entire brain at 1 mg/kg. ASA produced a 60% reduction in the carbon-deficient area in the injected side and a 62% reduction in the entire brain at 1 mg/kg. Ifenprodil at 1 mg/kg produced only a 19% reduction in the carbon-deficient area in the injected side.

摘要

在麻醉兔身上研究了6-[4-(1-环己基-1H-四氮唑-5-基)丁氧基]-3,4-二氢-2(1H)-喹啉酮(西洛他唑,OPC-13013)、乙酰水杨酸(ASA)和艾芬地尔对实验性诱导脑梗死的影响。通过向单侧颈内动脉注射剂量为0.5mg/kg的花生四烯酸(AA)来诱导脑梗死。注射AA后,用印度墨汁灌注大脑,通过计算半球灌注面积的百分比来确定血栓形成程度。颈内动脉注射AA在注射侧产生了占半球84%的无灌注区域,在未注射侧产生了占半球41%的无灌注区域。静脉注射0.1mg/kg的西洛他唑未使缺碳区域有明显减少,但在1mg/kg时,注射侧减少了49%,全脑减少了55%。1mg/kg的ASA使注射侧缺碳区域减少了60%,全脑减少了62%。1mg/kg的艾芬地尔仅使注射侧缺碳区域减少了19%。

相似文献

1
Effect of cilostazol on experimental cerebral infarction in rabbits.西洛他唑对兔实验性脑梗死的影响。
Arzneimittelforschung. 1986 Jul;36(7):1022-4.
2
Effect of cilostazol on platelet aggregation and experimental thrombosis.西洛他唑对血小板聚集和实验性血栓形成的影响。
Arzneimittelforschung. 1985;35(7A):1144-9.
3
Effect of cilostazol, a new antithrombotic drug, on an experimental model of peripheral circulation insufficiency.
Arzneimittelforschung. 1985;35(7A):1154-6.
4
Long-term effect of cilostazol on cerebral blood flow in chronic cerebral infarction.西洛他唑对慢性脑梗死脑血流量的长期影响。
Arzneimittelforschung. 1985;35(7A):1193-7.
5
Increased external carotid artery blood flow in headache patients induced by cilostazol. Preliminary communication.
Arzneimittelforschung. 1990 May;40(5):587-8.
6
General pharmacological properties of cilostazol, a new antithrombotic drug. Part II: Effect on the peripheral organs.新型抗血栓药物西洛他唑的一般药理学特性。第二部分:对周围器官的作用。
Arzneimittelforschung. 1985;35(7A):1163-72.
7
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2-(1H)quinolinone (cilostazol), a phosphodiesterase type 3 inhibitor, reduces infarct size via activation of mitochondrial Ca2+-activated K+ channels in rabbit hearts.6-[4-(1-环己基-1H-四氮唑-5-基)丁氧基]-3,4-二氢-2-(1H)喹啉酮(西洛他唑),一种3型磷酸二酯酶抑制剂,通过激活兔心脏线粒体钙激活钾通道来减小梗死面积。
J Pharmacol Exp Ther. 2008 Jul;326(1):100-4. doi: 10.1124/jpet.108.136218. Epub 2008 Apr 1.
8
The metabolism of a new antithrombotic and vasodilating agent, cilostazol, in rat, dog and man.新型抗血栓形成和血管舒张剂西洛他唑在大鼠、犬和人体内的代谢
Arzneimittelforschung. 1985;35(7A):1133-40.
9
General pharmacological properties of cilostazol, a new antithrombotic drug. Part I: Effects on the central nervous system.新型抗血栓药物西洛他唑的一般药理学特性。第一部分:对中枢神经系统的作用。
Arzneimittelforschung. 1985;35(7A):1157-62.
10
Effect of cilostazol, a new antithrombotic drug, on cerebral circulation.
Arzneimittelforschung. 1985;35(7A):1149-54.

引用本文的文献

1
Clinical efficacy and safety of cilostazol: a critical review of the literature.西洛他唑的临床疗效和安全性:文献综述。
Drugs. 2015 Mar;75(4):377-95. doi: 10.1007/s40265-015-0364-3.
2
Anti-platelet therapy: phosphodiesterase inhibitors.抗血小板治疗:磷酸二酯酶抑制剂。
Br J Clin Pharmacol. 2011 Oct;72(4):634-46. doi: 10.1111/j.1365-2125.2011.04034.x.